Related Experiment Video
Updated: Dec 24, 2025
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Improving Evidence Based Bronchiolitis Care
1Children's National Medical Center in Washington, D.C.
Insights
Bronchiolitis management in infants should focus on supportive care, not unproven therapies. Evidence-based clinical pathways can reduce hospitalizations and costs for this common childhood illness.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Bronchiolitis is a leading cause of infant hospitalization.
- Current clinical guidelines recommend supportive care, discouraging pharmacotherapies and diagnostics.
- Widespread use of non-recommended treatments and inter-hospital variations persist in the US.
Purpose of the Study:
- To review evidence-based management of bronchiolitis.
- To optimize resource utilization and decrease healthcare costs.
- To reduce unnecessary hospitalizations for infants and children.
Main Methods:
- Review of current evidence on bronchiolitis management.
- Analysis of recommended versus non-recommended therapeutic interventions.
- Examination of the impact of standardized clinical pathways.
Main Results:
- Evidence does not support routine use of chest radiographs, viral testing, or laboratory evaluations.
- Routine bronchodilators (albuterol, epinephrine), corticosteroids, and hypertonic saline are not recommended.
- Recommended interventions include hydration, nutritional support, supplemental oxygen, and respiratory support.
Conclusions:
- Standardizing bronchiolitis care with evidence-based pathways is crucial.
- Implementation can optimize resource use, improve patient care, and reduce hospital stays and costs.
- Focusing on supportive care aligns with current evidence and best practices.
Abstract:
Bronchiolitis is the number one cause of hospitalization in infants during the first year of life. Clinical guidelines recommend primarily supportive care and discourage use of pharmacotherapies and diagnostics. However, there continues to be widespread use of non-recommended therapies and variation in the use of therapeutic interventions among hospitals in the United States. Here we review evidence-based management of this common disease in order to optimize resource utilization, decrease healthcare costs, and decrease unnecessary hospitalization. Current evidence does not support the routine use of chest radiographs, viral testing or laboratory evaluation in children with bronchiolitis. In addition, routine administration of bronchodilators, including albuterol and nebulized epinephrine, corticosteroids and hypertonic saline are not recommended for infants and children with bronchiolitis. Intravenous or nasogastric hydration and nutritional support, supplemental oxygen, and respiratory support are recommended. Standardization of bronchiolitis care with evidence based institutional clinical pathways spanning ED to inpatient care can help optimize resource utilization while simultaneously improving care of bronchiolitis and reducing hospital length of stays and costs.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Asthma-IV: Nursing Management
First, in...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: